deltorphin ii, ala(2)- has been researched along with dexmedetomidine in 1 studies
| Studies (deltorphin ii, ala(2)-) | Trials (deltorphin ii, ala(2)-) | Recent Studies (post-2010) (deltorphin ii, ala(2)-) | Studies (dexmedetomidine) | Trials (dexmedetomidine) | Recent Studies (post-2010) (dexmedetomidine) |
|---|---|---|---|---|---|
| 233 | 0 | 20 | 5,332 | 1,643 | 4,186 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banfor, PN; Grabow, TS; Hammond, DL; Hurley, RW | 1 |
1 other study(ies) available for deltorphin ii, ala(2)- and dexmedetomidine
| Article | Year |
|---|---|
Supraspinal and spinal delta(2) opioid receptor-mediated antinociceptive synergy is mediated by spinal alpha(2) adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analgesics, Opioid; Anesthesia, Spinal; Animals; Dexmedetomidine; Drug Synergism; Injections, Spinal; Male; Nociceptors; Norepinephrine; Oligopeptides; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Opioid, delta; Spinal Cord; Yohimbine | 1999 |